会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • MICELLES AND NANOEMULSIONS FOR PREVENTATIVE AND REACTIVE TREATMENT OF ATHEROSCLEROSIS
    • 用于预防和反应性治疗甲状腺功能亢进症的细胞和纳米抗体
    • WO2006135415A2
    • 2006-12-21
    • PCT/US2005/031840
    • 2005-09-08
    • UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.VARSHNEY, ManojSHAH, Dinesh, O.
    • VARSHNEY, ManojSHAH, Dinesh, O.
    • A61K9/1075
    • The subject invention is directed to microemulsion-based (ME) nanoparticles and methods of using same. The ME nanoparticles of the subject invention encompass self-assemblies of oil in water emulsions in the presence of at least two emulsifiers. One of the emulsifiers is a salt of a fatty acid, and the combined concentration of the at least two emulsifiers is sufficiently large to produce micelles, wherein the oil droplets are the hydrophobic core of the micelles. The subject invention also contemplates methods of modifying lipids, high density lipoprotein (HDL), and low density lipoprotein (LDL) in blood by contacting the blood with the ME nanoparticles of the subject invention. Another aspect concerns methods for treating atherosclerosis by administering the ME nanoparticles of the subject invention to a patient in need thereof.
    • 本发明涉及基于微乳液的(ME)纳米颗粒及其使用方法。 本发明的ME纳米颗粒包括在至少两种乳化剂存在下的水包油乳液的自组装。 乳化剂之一是脂肪酸的盐,并且至少两种乳化剂的组合浓度足够大以产生胶束,其中油滴是胶束的疏水核心。 本发明还考虑通过使血液与本发明的ME纳米颗粒接触来改变血液中脂质,高密度脂蛋白(HDL)和低密度脂蛋白(LDL)的方法。 另一方面涉及通过将本发明的ME纳米颗粒给予有需要的患者来治疗动脉粥样硬化的方法。
    • 4. 发明申请
    • TARGETED CELLULAR SELECTIVITY OF SURFACE ACTIVE MOLECULES
    • 表面活性分子的靶向细胞选择性
    • WO2009100011A2
    • 2009-08-13
    • PCT/US2009032851
    • 2009-02-02
    • UNIV FLORIDAMOUDGIL BRIJ MVARSHNEY MANOJGROBMYER STEPHEN R
    • MOUDGIL BRIJ MVARSHNEY MANOJGROBMYER STEPHEN R
    • A61K31/765A61K49/06A61P35/00
    • A61K49/0017A61K31/765A61K47/543A61K47/60
    • A method for the treatment of cancer involves delivering a surface active agent to an organism, where the surface active agent selectively partitions to and kills cancer cells as opposed to healthy cells. The surface active agent can be an ionic or a non-ionic surfactant with a HLB of less than 29 or a mixture of surface active agents with a HLB of less than 40, where the hydrophobic portion is a lesser fraction of the surface active agent than the hydrophilic portion. A fluorescence method of detecting and locating cancer cells in an organism involves delivering a surface active agent, where the surface active agent includes a fluorescence moiety that upon selective partitioning of the surface active agent to the cancer cells and irradiation by a radiation source to excite the fluorescence moiety, a fluorescence emission is observed permitting the detection and location of the cancerous tissue by local volumes of relatively high intensity emission.
    • 用于治疗癌症的方法包括将表面活性剂递送至生物体,其中表面活性剂选择性分配并杀死癌细胞而非健康细胞。 表面活性剂可以是HLB小于29的离子或非离子表面活性剂或HLB小于40的表面活性剂的混合物,其中疏水部分是表面活性剂的较少部分 亲水部分。 检测和定位生物体中的癌细胞的荧光方法涉及递送表面活性剂,其中表面活性剂包括荧光部分,所述荧光部分在表面活性剂选择性分配到癌细胞上并通过辐射源辐射以激发 荧光部分,观察到荧光发射,允许通过相对高强度发射的局部体积检测和定位癌组织。
    • 5. 发明申请
    • MICELLES AND NANOEMULSIONS FOR PREVENTATIVE AND REACTIVE TREATMENT OF ATHEROSCLEROSIS
    • 用于预防和反应性治疗甲状腺功能亢进症的细胞和纳米抗体
    • WO2006135415A3
    • 2007-03-01
    • PCT/US2005031840
    • 2005-09-08
    • UNIV FLORIDAVARSHNEY MANOJSHAH DINESH O
    • VARSHNEY MANOJSHAH DINESH O
    • A61K9/107
    • A61K9/1075
    • The subject invention is directed to microemulsion-based (ME) nanoparticles and methods of using same. The ME nanoparticles of the subject invention encompass self-assemblies of oil in water emulsions in the presence of at least two emulsifiers. One of the emulsifiers is a salt of a fatty acid, and the combined concentration of the at least two emulsifiers is sufficiently large to produce micelles, wherein the oil droplets are the hydrophobic core of the micelles. The subject invention also contemplates methods of modifying lipids, high density lipoprotein (HDL), and low density lipoprotein (LDL) in blood by contacting the blood with the ME nanoparticles of the subject invention. Another aspect concerns methods for treating atherosclerosis by administering the ME nanoparticles of the subject invention to a patient in need thereof.
    • 本发明涉及基于微乳液的(ME)纳米颗粒及其使用方法。 本发明的ME纳米颗粒包括在至少两种乳化剂存在下的水包油乳液的自组装。 乳化剂之一是脂肪酸的盐,并且至少两种乳化剂的组合浓度足够大以产生胶束,其中油滴是胶束的疏水核心。 本发明还考虑通过使血液与本发明的ME纳米颗粒接触来改变血液中脂质,高密度脂蛋白(HDL)和低密度脂蛋白(LDL)的方法。 另一方面涉及通过将本发明的ME纳米颗粒给予有需要的患者来治疗动脉粥样硬化的方法。